HIMS Stock Faces FTC Lawsuit as Morningstar Maintains No Moat Rating
Hims & Hers Health, Inc. (HIMS) faces a Federal Trade Commission lawsuit filed this week alongside Utah and Los Angeles County, alleging the company misled consumers over subscriptions and cancellations and shared sensitive health information with Meta and Snap. Morningstar called the case a 'new le
HIMS3.79%
LucasBennett·07-31 01:32



